Publications

Explore our research outputs and impact in-depth.

Cytokine modulation of natural killer cells to develop a novel immunotherapy

2024

Type: thesis

Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation

Hannah Bauer-Smith, Abigail S.L. Sudol, Stephen A. Beers & Max Crispin, 2023, Biochimica et Biophysica Acta (BBA) - Biomembranes, 1867(11)

DOI: 10.1016/j.bbagen.2023.130448

Type: article

Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma

Charles N. Birts, Constantinos Savva, Stéphanie A. Laversin, Alicia Lefas, Jamie Krishnan, Aron Schapira, Margaret Ashton-Key, Max Crispin, Peter W.M. Johnson, Jeremy P. Blaydes, Ellen Copson, Ramsey I. Cutress & Stephen A. Beers, 2022, Scientific Reports, 12(1)

DOI: 10.1038/s41598-022-11696-6

Type: article

Immune responses to SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies

Sean H. Lim, Beth Stuart, Debora Joseph-Pietras, Marina Johnson, Nicola Campbell, Adam Kelly, Danielle Jeffrey, Anna H Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Helen Coleman, Carina Mundy, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O'Callaghan, Graham P Collins, Tobias Menne, Saul N Faust, Christopher P Fox, Matthew Ahearne, Peter W M Johnson, Andrew J Davies & David Goldblatt, 2022, Nature cancer, 3(5), 552-564

DOI: 10.1038/s43018-022-00364-3

Type: article

Exploring the pathways to chronic lymphocytic leukemia

Freda Stevenson, Francesco Forconi & Thomas J Kipps, 2021, Blood, 138(10), 827-835

DOI: 10.1182/blood.2020010029

Type: article